Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Two go-to MD peeps, one of them new to me, follow the crumbs of clues to ... heresy?
Inadequate physical activity was associated with liver steatosis regardless of body mass index.
Resmetirom is the first drug to show both MASH resolution and fibrosis improvement in a late-stage clinical trial.
For both adolescents and adults, body mass index and waist circumference were linked to greater risk of MASLD.
Skipping breakfast and late-night eating can worsen MASLD, while intermittent fasting may help.
MASLD and MASH can lead to liver fibrosis, cirrhosis and liver cancer.
Some HIV meds have been linked to fatty liver disease and weight gain.
An increase in fatty liver disease could double liver cancer cases and nearly triple the need for transplants by 2050.
Name change emphasizes the role of metabolic dysfunction in fatty liver disease.
NAFLD is associated with risk factors such as obesity and inflammatory biomarkers and with events including heart attacks and strokes.
Eating one meal a day certainly simplifies life, but is it a good idea?
Study findings suggest people with chronic liver disease should be prioritized for booster shots.
The burden of viral and nonviral liver disease remains high even in the setting of hepatitis C microelimination.
People with advanced fibrosis—not just cirrhosis—were at greater risk for hepatocellular carcinoma.
The buildup of fat in the liver can lead to fibrosis, cirrhosis and liver cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.